LONDON, Jan 30 (Reuters) - The relentless coffee price rally continued on Thursday as arabica hit a new record approaching $4 per lb on extremely tight supplies and fears over the outlook for the ...

Goldman Sachs' Ryan Nolan, a partner in the technology, media and telecommunications group and global co-head of software investment banking, is leaving the bank, according to a memo seen by Reuters ...

Parker-Hannifin on Thursday posted a quarterly profit that surpassed estimates, driven by higher demand for its aircraft parts and components, sending its shares up 6% in morning trade.

A British man captured fighting on the Ukrainian side in Russia's Kursk region will face terrorism and mercenary charges that could see him jailed for years, Russian state investigators said on ...

Greece's economy is projected to grow 2.1% in 2025, mainly driven by investment, the International Monetary Fund mission said ...

Paraguay international Miguel Almiron has returned to Major League Soccer (MLS) side Atlanta United for an undisclosed fee, after six years at Newcastle United, both clubs said on Thursday.

A further European Central Bank interest rate cut is likely to go through in March without much resistance among policymakers before the debate between them on further easing becomes more heated, ...

The Las Vegas Raiders are re-signing Patrick Graham to remain their defensive coordinator, multiple media outlets reported.

Walmart Canada said on Thursday it is investing about C$6.5 billion ($4.51 billion) to build new stores and expand its supply chain, marking its biggest ever investment since opening its first store ...

Wall Street shares rallied on Thursday, as investors cheered earnings from Meta , but shunned Microsoft , while the dollar dipped, further boosting gold prices.

Brazilian President Luiz Inacio Lula da Silva on Thursday voiced support for government non-interference in monetary policy and the pricing strategy of state-run oil giant Petrobras, in ...

Novo Nordisk said on Thursday it has not yet posted details about a new trial of its experimental next-generation obesity drug CagriSema, which it announced it would start after late-stage trial data ...